Abstract
Antiapoptotic agents based on 1-benzyl-3-(5′-hydroxymethyl-2′-furyl)indazole (22, YC-1) derivatives were explored for effective treatment of sepsis and septic shock. We found that compound 22, 1-benzyl-3-(5′-methoxymethyl-2′-furyl)indazole (27), and 1-phenyl-3-(5′-hydroxymethyl-2′-furyl)-indazole (23) were the most effective inhibitors of sodium nitroprusside-induced vascular smooth muscle cell apoptosis. These three compounds are proposed as potential therapeutic agents for the treatment of sepsis.
| Original language | English |
|---|---|
| Pages (from-to) | 4947-4949 |
| Number of pages | 3 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 45 |
| Issue number | 23 |
| DOIs | |
| Publication status | Published - Nov 7 2002 |
ASJC Scopus subject areas
- Drug Discovery
- Molecular Medicine
Fingerprint
Dive into the research topics of '1-Benzyl-3-(5′-hydroxymethyl-2′-furyl)-indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS